Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors: focus on timing, sequencing, regimen initiation, and maintenance strategies using somatostatin analogs, targeted agents, and peptide receptor radiotherapy.
Clin Adv Hematol Oncol
; 16 Suppl 17(9): 11-14, 2018 Sep.
Article
in En
| MEDLINE
| ID: mdl-30807563
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Somatostatin
/
Molecular Targeted Therapy
/
Hormones
/
Neoplasm Metastasis
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Clin Adv Hematol Oncol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2018
Document type:
Article